Open access peer-reviewed chapter

Prospective Study of Triple Combination Chemotherapy Consisting of Paclitaxel, S-1, and 24-Hour Infusion of Cisplatin (PSC) for Inoperable Highly Advanced Gastric Cancer

By Kenji Ina, Ryuichi Furuta, Takae Kataoka, Satoshi Kayukawa and Hiroaki Iwase

Submitted: November 8th 2010Reviewed: February 16th 2011Published: July 18th 2011

DOI: 10.5772/20268

Downloaded: 882

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike-3.0 License, which permits use, distribution and reproduction for non-commercial purposes, provided the original is properly cited and derivative works building on this content are distributed under the same license.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Kenji Ina, Ryuichi Furuta, Takae Kataoka, Satoshi Kayukawa and Hiroaki Iwase (July 18th 2011). Prospective Study of Triple Combination Chemotherapy Consisting of Paclitaxel, S-1, and 24-Hour Infusion of Cisplatin (PSC) for Inoperable Highly Advanced Gastric Cancer, Management of Gastric Cancer Nabil Ismaili, IntechOpen, DOI: 10.5772/20268. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/management-of-gastric-cancer/prospective-study-of-triple-combination-chemotherapy-consisting-of-paclitaxel-s-1-and-24-hour-infusi" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

882total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

A Rare Gastric Carcinoma- Neuroendocrine Tumors

By Petar Svorcan, Jelena Djordjevic and Branko Maksimovic

Related Book

First chapter

Colorectal Cancer: It Starts and It Runs

By Rajunor Ettarh

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us